Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.799988
Abstract: Background HER2 is one of the most extensively studied oncogenes in solid tumors. However, the association between tumor microenvironment (TME) and HER2 mutation remains elusive, and there are no specific therapies for HER2-mutated tumors. Immune… read more here.
Keywords: immunotherapy outcomes; her2 mutations; solid tumors; mutation ... See more keywords